297 related articles for article (PubMed ID: 17868924)
1. Antibiotic synergy testing should not be routine for patients with cystic fibrosis who are infected with multiresistant bacterial organisms.
Aaron SD
Paediatr Respir Rev; 2007 Sep; 8(3):256-61. PubMed ID: 17868924
[TBL] [Abstract][Full Text] [Related]
2. A retrospective analysis of biofilm antibiotic susceptibility testing: a better predictor of clinical response in cystic fibrosis exacerbations.
Keays T; Ferris W; Vandemheen KL; Chan F; Yeung SW; Mah TF; Ramotar K; Saginur R; Aaron SD
J Cyst Fibros; 2009 Mar; 8(2):122-7. PubMed ID: 19064337
[TBL] [Abstract][Full Text] [Related]
3. Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomised, double-blind, controlled clinical trial.
Aaron SD; Vandemheen KL; Ferris W; Fergusson D; Tullis E; Haase D; Berthiaume Y; Brown N; Wilcox P; Yozghatlian V; Bye P; Bell S; Chan F; Rose B; Jeanneret A; Stephenson A; Noseworthy M; Freitag A; Paterson N; Doucette S; Harbour C; Ruel M; MacDonald N
Lancet; 2005 Aug 6-12; 366(9484):463-71. PubMed ID: 16084254
[TBL] [Abstract][Full Text] [Related]
4. Editorial overview: clinical utility of synergy testing for multidrug resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis.
Middleton PG
Paediatr Respir Rev; 2007 Sep; 8(3):262-3, quiz 263-4. PubMed ID: 17868925
[No Abstract] [Full Text] [Related]
5. The relevance of the polymicrobial nature of airway infection in the acute and chronic management of patients with cystic fibrosis.
Sibley CD; Parkins MD; Rabin HR; Surette MG
Curr Opin Investig Drugs; 2009 Aug; 10(8):787-94. PubMed ID: 19649923
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility of synergy testing for multidrug-resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis: 'the motion for'.
Saiman L
Paediatr Respir Rev; 2007 Sep; 8(3):249-55. PubMed ID: 17868923
[TBL] [Abstract][Full Text] [Related]
7. Clinical impact of reducing routine susceptibility testing in chronic Pseudomonas aeruginosa infections in cystic fibrosis.
Etherington C; Hall M; Conway S; Peckham D; Denton M
J Antimicrob Chemother; 2008 Feb; 61(2):425-7. PubMed ID: 18156280
[TBL] [Abstract][Full Text] [Related]
8. Comparison of hospital and home intravenous antibiotic therapy in adults with cystic fibrosis.
Esmond G; Butler M; McCormack AM
J Clin Nurs; 2006 Jan; 15(1):52-60. PubMed ID: 16390524
[TBL] [Abstract][Full Text] [Related]
9. Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis.
Waters V; Ratjen F
Cochrane Database Syst Rev; 2008 Jul; (3):CD006961. PubMed ID: 18646176
[TBL] [Abstract][Full Text] [Related]
10. Diagnosing and managing infection in CF.
Ratjen F
Paediatr Respir Rev; 2006; 7 Suppl 1():S151-3. PubMed ID: 16798546
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic use in cystic fibrosis.
Eisenberg JD
Curr Opin Pulm Med; 1996 Nov; 2(6):439-46. PubMed ID: 9363182
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary infections in children with cystic fibrosis.
Stutman HR; Marks MI
Semin Respir Infect; 1987 Sep; 2(3):166-76. PubMed ID: 3317617
[TBL] [Abstract][Full Text] [Related]
13. The cystic fibrosis airway microbiome.
Rabin HR; Surette MG
Curr Opin Pulm Med; 2012 Nov; 18(6):622-7. PubMed ID: 22965275
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility and synergy studies of Burkholderia cepacia complex isolated from patients with cystic fibrosis.
Zhou J; Chen Y; Tabibi S; Alba L; Garber E; Saiman L
Antimicrob Agents Chemother; 2007 Mar; 51(3):1085-8. PubMed ID: 17158942
[TBL] [Abstract][Full Text] [Related]
15. [Antibiotic treatment of lung disease in cystic fibrosis].
Biasini GC; Pistocchi E; Miano A
Pediatr Med Chir; 1983; 5(4):157-60. PubMed ID: 6647075
[TBL] [Abstract][Full Text] [Related]
16. Cystic fibrosis infections: treatment strategies and prospects.
George AM; Jones PM; Middleton PG
FEMS Microbiol Lett; 2009 Nov; 300(2):153-64. PubMed ID: 19674113
[TBL] [Abstract][Full Text] [Related]
17. Sputum antibiotic concentrations: implications for treatment of cystic fibrosis lung infection.
Moriarty TF; McElnay JC; Elborn JS; Tunney MM
Pediatr Pulmonol; 2007 Nov; 42(11):1008-17. PubMed ID: 17902147
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients.
Worlitzsch D; Rintelen C; Böhm K; Wollschläger B; Merkel N; Borneff-Lipp M; Döring G
Clin Microbiol Infect; 2009 May; 15(5):454-60. PubMed ID: 19196263
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary infection and antibiotic treatment in patients with cystic fibrosis.
Chest; 1988 Aug; 94(2 Suppl):97S-169S. PubMed ID: 3396440
[No Abstract] [Full Text] [Related]
20. The approach to Pseudomonas aeruginosa in cystic fibrosis.
Bendiak GN; Ratjen F
Semin Respir Crit Care Med; 2009 Oct; 30(5):587-95. PubMed ID: 19760546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
